Candel Therapeutics has initiated the global pivotal Phase 3 AURORA trial to evaluate aglatimagene besadenovec (CAN-2409) combined with valacyclovir and pembrolizumab in patients with advanced non-squamous non-small cell lung cancer (NSCLC) who have not responded adequately to prior immune checkpoint inhibitors and chemotherapy. The trial will compare this treatment against standard docetaxel chemotherapy, enrolling patients worldwide across 150 sites with overall survival as the primary endpoint. This trial builds on promising Phase 2 results showing extended survival, addressing a critical unmet need for patients with limited options after progression on current therapies. The FDA has granted Fast Track Designation to aglatimagene for NSCLC, highlighting its potential as a novel immunotherapy.
The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...
The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...
New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
